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Abstract
Cyclophosphamide (CYP) was one of the first chemotherapy drugs developed and used to
treat several types of cancer, by disrupting proliferative cells. Unfortunately, CYP is unable
to differentiate between cancerous cells and healthy cells turning over which ultimately kills
normally functioning cells, including those of the taste system. This loss of taste cells may
result in dysgeusia (altered sense of taste), hypogeusia (reduced taste ability) or ageusia
(inability to detect any tastes), eventually leading to malnutrition and poor prognosis for
patients. The notch signaling pathway is one of the most important pathways involved in the
differentiation and fate of neural stem cells (Hitoshi et al., 2002). A previous study looked at
genes expressed in developing circumvallate taste cells and found that notch signaling
remains active in adult mice to determine cell lineage as the sensory cells are continuously
replaced (Seta, Seta, & Barlow, 2003). The current research uses immunohistochemistry to
identify the presence of notch signaling following injury by CYP. It was hypothesized that if
Notch1 is involved in taste cell replacement, we predict the Notch1 signal should be
amplified following challenge by cyclophosphamide.
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Introduction
Cancer and Cyclophosphamide (CYP)
Cancer is the leading cause of death in all developed countries and the second in
developing (Jemal et al., 2011). Several treatment options are available for the numerous
types of cancer including chemotherapy and radiation treatment. CYP is one of the oldest
forms of chemotherapy and is now one of the most
commonly administered anticancer drugs. CYP is
an alkylating drug that is mainly used to treat
malignant lymphomas, leukemias, carcinomas of
the ovary, and breast cancer (de Jonge, Huitema,
Rodenhuis, & Beijnen, 2005). CYP (Figure 1) is a
prodrug, which means it is administered in an
inactive form and subsequently metabolized in
the liver by p450 cytochrome oxidase into its

Figure 1. Mechanism of CYP metabolism. Identifying
the pathway from inactive cyclophosphamide (black
box), metabolism by cytochrome P-450 in the liver, and
further metabolism into its active, cytotoxic and
alkylating compounds acrolein and phosphoramide
mustard, respectively (red boxes). Adapted from Emadi,
Jones, & Brodsky, 2009)

active products. CYP is initially broken down into the unstable product 4hydroxycyclophosphamide, which tautomerizes to aldophosphamide. Aldophosphamide is
then converted into the nontoxic compound carboxy phosphamide and the active, toxic,
compounds acrolein and phosphoramide mustard. Most of aldophosphamide is converted into
these cytotoxic products which is how CYP exerts its detrimental effects. Acrolein is an
unsaturated aldehyde compound that is cytotoxic along with phosphoramide mustard.
Phosphoramide mustard manifests its toxicity by creating both intra- and interstrand crosslinks in DNA during the S-phase (de Jonge et al., 2005). These cross-links inhibit DNA
replication and further cell proliferation, ultimately leading to apoptosis, or programmed cell
death. Although CYP is great at targeting rapidly proliferating cells, it cannot differentiate
between healthy, proliferating cells and cancerous ones. The prognosis of the patient’s
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disease largely depends on the efficacy of the drugs but the side effects cannot be overlooked.
It was reported that 40% of cancer patients hospitalized suffer from malnutrition (Comeau,
Epstein, & Migas, 2001). Loss of taste because of the chemotherapy treatment can result in a
reduced appetite in the patient and an overall reduced quality of life. This leads to
malnutrition and further dietary deficiencies ultimately causing more severe health problems.
Overview of the Taste System
Taste is one of our chemical senses that allows us to distinguish between healthy,
nutritious foods and poisonous, harmful foods. Through evolution we have learned to reject
bitter substances due to their relation to bitter-tasting poisonous compounds produced by
plants and animals. We have also learned that sour tasting compounds can indicate something
that is rotten, such as fruit, or acidic. The rest of the typically distinguished tastes are sweet,
savory (umami) and salty (Barlow, 2015). Taste has proven to be an imperative sense
throughout evolution which is why experiencing hypogeusia (decreased sensitivity),
dysgeusia (distortion of taste), or ageusia (absence of taste) can potentially be fatal.
The taste system is a chemical sensory system that is composed of taste buds
containing taste sensory cells, which are located throughout the oral cavity and pharyngeal
cavities. Taste buds are innervated by cranial nerves VII, IX, and X. Most taste buds on the
tongue’s surface are part of specialized papillae called fungiform (FF) (Figure 2),
circumvallate (CV) (Figure 2), or foliate taste papillae. Within each circumvallate and foliate
taste papillae lie hundreds of taste buds that contain the specialized taste sensory cell (TSCs).
Each FF taste papillae contains one taste bud made up of a cluster of cells. Each taste bud
contains roughly between 50-100 TSCs that are differentiated into type I, II, and III cells
(Barlow, 2015; Barlow & Ophir, 2015; Hamamachi, Asano-Miyoshi, & Emori, 2006; Yee et
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al., 2013; Seta, Toyono, Kataoka, Toyoshima, 2005). Each taste cell type is morphologically
and functionally different.
Taste Cell Types. The most common, type I cells, are
thought to be salt detector cells. They also the glial-like cells
for the taste system because they appear to clear
neurotransmitters and ensheath Type II and III taste cells with
lamellar processes (Perea-Martinez, Nagai, & Chaudhari,
2013; Barlow & Ophir, 2015). Type I cells can be identified
by their expression of NTPDase2, which converts ATP to
ADP. This is likely due to their neurotransmitter clearance

Figure 2. Diagram of tongue
morphology. CV papilla (red box),
located at the posterior, houses taste buds
(green boxes). FF papillae, located at
anterior two-thirds of tongue (blue box),
house single taste bud (purple box).
Adapted from Barlow, 2015.

mechanism. Type II cells are the sweet, bitter, and umami (savory) detectors. Type II cells
can be identified by the expression of PLCβ2, which is involved in the g-protein-coupled
receptor cascade. These cells have been shown to use ATP as neurotransmitters to send
signals to sensory nerves. They do, however, lack regular presynaptic specializations and
freely release their ATP molecules instead of enclosed in vesicles (Finger et al., 2005;
Chaudhari, 2014). This supports the neurotransmitter clearing capabilities of Type I cells.
Type III cells are sour detectors and appear to be most neuron-like, due to their formation of
traditional synapses onto sensory nerve fibers of cranial nerves VII and IX. They can be
identified by their expression of the SNAP-25 molecule, which is part of the SNARE
complex (Barlow, 2015).
Development
Developmental pathways and signaling mechanisms govern when, where, and how
quickly the TSCs arrive at their specific location. Taste bud development and innervation is
well known in rodents and is said to begin at embryonic (E) day 11 in mice, where the tongue
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rudiment forms and is covered by a homogenous epithelial bilayer (Kapsimali & Barlow,
2013). By E12-12.5, taste placodes appear as foci of columnar epithelia in locations where
fungiform and circumvallate papillae will form. At E14.5, invagination is evident to create
taste papillae with distinct mesenchymal cores. Finally, taste nerve fibers reach and then
penetrate the taste epithelium. It had been previously thought that innervation was required
for taste bud development, however, we now know this is not the case. Barlow, Chien, and
Northcutt (1996) elucidated that innervation is independent of taste bud development in rats
and other mammals. They found that taste papillae or their primordia form in the epithelium
prior to contact by neurites in vivo. They also found that the cranial nerve fibers (VII, IX, and
X) that innervate the taste buds grow directly to the fungiform papillae, which suggests that
the taste bud primordia may attract these nerves via a chemical cue (Barlow et al., 1996). The
current understanding of taste bud development is that, embryonically, taste bud development
is nerve-independent, but postnatally during differentiation of taste bud cells, innervation is
required (Kapsimali & Barlow, 2013). At birth, taste precursor cells within the taste buds
express embryonic markers, such as Shh, Sox2, and keratin-8 (K8), in the absence of
innervation (Luo, Okubo, Randell, & Hogan, 2009). They do not, however, express any
differentiated cell markers. The first postnatal week was shown to be a crucial time point for
TSC differentiation in circumvallate papillae. Even when there was damage and regrowth of
the innervated circumvallate papillae prior to complete differentiation, the resulting number
of taste buds in the epithelium was permanently decreased. During this week, they will begin
to express specific taste cell type markers indicating differentiation (Kapsimali & Barlow,
2013; Barlow, 2015).
Taste Cell Lifespans. The focus of the current research was on the TSC replacement
cycle that occurs in adult mice circumvallate papillae. Many cell-signaling pathways are at
work throughout the life of the animal regarding taste cell turnover. Parea-Martinez et al.
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(2013) estimates that the population made up of neither Type II cells nor Type III cells,
mainly Type I cells and undifferentiated or immature cells have half-lives of 8 and 24 days,
respectively. Type II cells have a half-life of 8 days and Type III cells have a half-life of 22
days (Perea-Martinez et al., 2013). Normally, due to the constant replacement of TSCs, there
is a varied number of taste cells that are mature, immature, and sloughing off at any one time
in the taste bud. Approximately 60-70% of the TSC population are differentiated cells, about
20-30% of cells are undergoing differentiation, and about 10% of cells are undergoing
apoptosis due to age (Barlow, 2015).
Taste cell Development/Replacement. TSCs come from a taste progenitor pool
located in a basal layer just outside of the taste bud and in areas adjacent to the taste buds
(Gaillard & Barlow, 2011). These cells are basal keratinocytes (Type IV cells) that appear to
be transit amplifying cells that move up along the basal lamina. They can be identified by
their expression of keratin-5 (K5+) and keratin-14 (K14+), which are intermediate filament
proteins necessary for epithelial cell structure. Depending on β-catenin expression by these
K5/K14+ cells, they will either end up as non-taste epithelium (low β-catenin expression) or
differentiated TSCs (higher β-catenin expression) (Castillo et al., 2014; Gaillard & Barlow,
2011; Okubo, Clark, & Hogan, 2009). Cells with higher β-catenin expression and subsequent
expression of Sonic Hedgehog (Shh) are postmitotic taste cell precursors that will ultimately
become differentiated TSCs. What dictates which type of TSC the precursors differentiate
into is the level of this β-catenin expression. Within these higher β-catenin expressing
K5/K14+ cells, relatively high β-catenin expression leads to Type I cells, mid β-catenin
expression leads to Type II cells, and low β-catenin leads to Type III cells. Finally, the low
level of β-catenin expression in the non-differentiated cells results in expression of keratin-13
(K13) which are differentiated keratinocytes that will end up as non-taste epithelium

11

surrounding the taste bud and making up most of the tongue surface (Castillo et al., 2014;
Gaillard & Barlow, 2011; Okubo et al., 2009).
Notch Signaling Pathway
Overview. The Notch signaling pathway is highly implicated in development
throughout the nervous system, and specifically in the cell fate decisions (Seta et al., 2003).
Notch is an evolutionarily conserved cell-cell signaling pathway that is composed primarily
of transmembrane surface receptor proteins and membrane-bound ligands that are expressed
on its neighbors that will ultimately activate the signaling cascade. Notch ligands have been
shown to contain epidermal growth factor (EGF) repeats that appear to be necessary for
proper binding to the transmembrane receptor protein. The initial two ligands shown to
contain EGF repeats that bonded with the notch receptor were Delta and Serrate (Rebay,
Fleming, Fehon, R. G. Cherbas, & P. Cherbas, 1991). However, years later it was shown that
another ligand named Jagged can also bind to the notch receptor and that it contains EGF
repeats (Lindsell, Shawber, Boulter, &Weinmaster 1995; Guarnaccia, Pintar, &Pongor, 2004;
Guruharsha, Kankel, & Spyros, 2012).
Notch1 Signaling Cascade. Notch1 signaling begins by the signaling cell’s
membrane-bound ligand, a Delta, Serrate, or Jagged, binding to the receiving cell’s
transmembrane Notch1 receptor protein. Following ligand binding, intracellular γ-secretase is
recruited to cleave the Notch intracellular domain (NICD). Then, the NICD translocates to
the nucleus, where it begins to directly influence transcription via binding proteins such as
protein recombining binding protein (RBPJ, or CBF1). Binding of RBPJ then activates
repressor type Hes genes. Hes binds directly to the promoter region of Mash1 inhibiting
expression and prevents certain neural differentiation (Seta et al., 2003; Guruharsha et al.,
2012). This implies that when Hes1 is downregulated, Mash1 expression upregulates and the
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cell is driven toward a neuronal fate (Seta et al., 2003). This result occurs in the presence of
the expression of Notch1. Notch1 is one of the three Notch homologs (1-3) identified in
mammals (Lindsell et al., 1995) that are involved in development. Notch1 has been shown to
be essential due to necessary cell-cell signaling and influence on downstream geneexpression. When Notch1 expression is disrupted, lethality occurs very early, before 11.5
days of gestation (Lindsell et al., 1995). Interestingly, the neural fate for developing cells is
dependent on multiple Hes genes, as well. Another route for cell differentiation and
regulation operates by inhibition of Hes1 via Hes6 activation, which leads to activation of
Mash1 expression and further differentiation. Activation via the latter pathway has been
shown to differentiate neuronal-like Type II and III cells, whereas via the former, support or
Type I cells prevail (Seta et al., 2003).
The fact that Notch1 acts to inhibit differentiation via activation of Hes1 and further
suppression of Mash1 largely contributes the results of the current study. Our findings
indicate that around day 4 post-injection, there is a decrease in Notch1 labelling followed by
a gradual increase. This increase in Notch1 could therefore be indicating the decreasing level
of specific Type II and Type III TSC differentiation and an increase in Type I TSC
differentiation.
Hypothesis
It was hypothesized that if Notch1 is involved in taste cell replacement, we predict the
Notch1 signal should be amplified following challenge by CYP.
Materials and Methods
Subjects
Male C57BL/6J mice were obtained from Jackson Laboratory (Bar Harbor, ME).
Mice were at least 8 weeks old and weighed between 23-26g at the beginning of the
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experiment. All procedures were approved by the Institutional Animal Care and Use
Committee at the University of Vermont, protocol number 14-003. The experiment was
designed to minimize the amount of mice required to test the experimental question.
Chemical Reagents
CYP (Cyclophosphamide monohydrate, 97%) was obtained from Acros Organics (New
Jersey, USA).
Tissue Preparation
The cellular morphology of circumvallate (CV) taste papillae and taste buds of the
tongue were examined at days 0 (saline), 3, 4, 5, 6, 7, 8, and 10 following a 75 mg/kg CYP
injection. Perfusions were done using PBS-heparin followed by 4% paraformaldehyde in PBS
(Electron Micros-copy Sciences, Hatfield, PA USA) and the tongues were harvested for
analysis. Following perfusion, tongues were cryoprotected using a 30% sucrose solution (2436 hrs) and then and kept at -80º C. CV tongue blocks were cryo-sectioned at a thickness of 6
µm. Every 8th section was mounted on one slide to ensure accurate quantitative evaluation of
taste buds and to prevent overlapping counts. Tissue collection began at the first sight of the
CV papillae, which was viewed under a dissecting scope. Slides kept at -20º C.
Immunohistochemistry of Notch1 labeling
Notch1 primary polyclonal antibody (Catalog # ab65297; Abcam, Cambridge, UK)
was used at 1:100 dilution for incubation at 4º C overnight and the secondary antibody was
Alexa 546 goat anti-rabbit used at 1:1000 dilution (Thermo Fisher, Waltham, MA). All slides
were counterstained using Sytox green (1:30,000; S7020, Molecular Probes, Eugene, OR) as
a nuclear marker.
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Statistical Analysis
All statistical analyses were done using SPSS software (SPSS Statistics, version 24,
IBM Corporation, Chicago, IL, USA) and Graphpad Prism 7 software. Analysis of variance
(ANOVA) procedures were used to compare the effects of CYP on Notch1 expressing cells
of the taste buds between each timepoint post-injection (PI). The independent variable, days
PI (8 levels), was treated as a between subject variable.
Image Capture Analysis
All images were captured using a Zeiss Axioskop2 with 20x magnification and with a
63x water immersion with a Photometric Cool SNA EZ camera and NIS Elements acquisition
and imaging software. Cell counts were taken using ImageJ (NIH, Bethesda, MD, USA).
Results
Overall, the results of this study identify a pattern in Notch1 signaling over the course
of 10 days PI. At day 0 CYP post injection, we should expect there to be uniform expression
of Notch1 throughout the taste bud. This indicates a basal level of Notch1 expression
throughout the taste bud as new differentiating cells replace the cells due to normal attrition
from aging. This is exactly what is observed. In Figure 3, Notch1 is expressed uniformly
throughout many cells. Therefore, days post-CYP injection, we should expect to see a drop in
Notch1 expression because the cells are dying off. An observable and statistically significant
drop in the number of labelled Notch1 taste cells appears at 4 days PI (Figure 4), which
subsequently begins to increase back towards the normal level. Figure 5 shows that the
number of labeled cells has increased gradually over the next 6 days.

15

Notch1 Localization
The Notch1 labeling at day 0, the labeling appears more localized to the nuclear
region of the cells and less on the cell membrane. At days 4 and 10, the Notch1 labeling
appears significantly more in the cell membrane and is less localized in the nuclear region.
Overall, the amount of labeling in day 4 CYP is Significantly lower than observed in Day 0
CYP mice.
A

B

C

D

E

Figure 3. Day 0 CYP; all taken at 20x. A) Original nuclear labeled (Sytox green). B)
Colorized green nuclear labeled. C) Original Notch1 labeled cells. D) Colorized red
Notch1 antibody. E) Merged, orange-colored cells show double labeled for Notch1
appearing in the nucleus (red arrow), as well as around the nucleus on the cell
membrane (white arrow). Uniform amount of notch signaling throughout taste bud
indicating basal amount of activation and therefor normal activation and replacement.

16

A

C

B

D

E
E

Figure 4. Day 4 CYP; all taken at 20x. A) Original nuclear labeled (Sytox green). B)
Colorized green nuclear labeled. C) Original Notch1 labeled cells. D) Colorized red
Notch1 antibody. E) Merged, Notch1 labeling seen almost exclusively in cell membranes.
Severely diminished amount of Notch1 labeling throughout the taste bud indicating low
levels of expression of Nocth1 due to CYP challenge.
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Figure 5. Day 10 CYP. Panel A) Taken at 20x. Composed of originally labeled (black
and white), colorized (green nuclear label, red antibody label), and larger merged image
(at right). Panel B) Taken at 63x with water immersion lens. Composed of originally
labeled (black and white), colorized (green nuclear label, red antibody label), and larger
merged image (at right). Bottom-right merged image shows 63x magnification of the
above corresponding image. Here, three cells (arrows) are labeled on their cell membranes
(red). The shape of the TSCs is also evident, as they have an elongated shape that points to
the apical end and extends towards the basilar end. The extent to which the cells extend to
each end depends on the type of TSC. It is unclear from the image what type of taste cell
is labeled.
Statistics
A one-way ANOVA was performed that identified a statistically significant effect
between the experimental timepoints. Post hoc comparisons (Sidak) comparing all days to
day 0 PI indicated that at days 3 and 4, there were significantly fewer (P<0.05) Notch1
labeled taste cells out of the total number of TSCs per taste bud compared to the other days
(Fig. 6). After day 4 the Notch1 labeled slowly increased, returning to baseline levels.
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*
*

Figure 6. Mean (± SEM) of labeled Notch1 cells in CV taste buds. Notch1-positive
cells in CV shows significant decrease following CYP injection indicating severe loss of
TSCs. Slowly, notch labeling increases over the course of 10 days. There was a significant
decrease in the number of labeled cells between day 0 (saline) and day 3, and day 0 and
day 4 (* P<0.05).
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Discussion
Notch signaling has been evolutionarily conserved and plays an imperative role in
determining cell fate in several types of developmental processes in many organisms
(Guruharsha et al., 2012; Seta et al., 2003). Previous research has implicated Notch signaling
in taste cell development and replacement. Different genes responsible for taste bud and TSC
development and taste cell
replacement have also been identified
including Hes1, Hes6, Notch1-4, and
Mash1 (Seta et al., 2003; Barlow,
2015). Embryologically, the process
by which taste buds develop has been
shown to be nerve-independent, but
that taste cell differentiation is nervedependent. As the animal matures,
taste cells die and must be replaced.
Many systems involved in
embryologic development also take
part in regular taste cell replacement
Figure 7. Taste cell renewal in adult mice. A) All 3 types of
taste cells in adult taste buds. Basal layer (green) shows where
progenitor pool is located as well as those adjacent to taste bud.
Basal keratinocytes (green) show asymmetric division (curved
arrow indicated keratinocyte replenishment). Differentiated
keratinocytes (orange) are non-taste cells. Post-mitotic taste
precursor cells (purple) eventually differentiate into taste cells
(type I, II, and III). B) Notch activity would be indicated where
Mash1 expression is indicated, depending on what type of Hes
activity is occurring. Adapted from Barlow, 2015.

throughout adult life, such as
Wnt/β-Catenin, Sonic Hedgehog
(Shh), and Notch. In adult animals,
it has been shown that there is a
progenitor cell population located

in the basal layer and adjacent taste epithelium of mature taste buds. When activated,
signaling pathways cause immature, nonmitotic cells to migrate into the taste bud and
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differentiate to end up in their final phenotype (Figure 6) (Barlow, 2015; Gaillard & Barlow,
2011; Okubo et al., 2009; Miura, Scott, Harada, & Barlow, 2014).
The previous mention of the effects of Hes1 on Hes6 may explain the observed trend
in Figure 6. When Notch1 becomes active and further activates Hes1 in the developing mouse
nervous system, it was shown that Mash1, which encodes a developmentally relevant Mash1
protein, is inhibited. This eventually leads the cells to a glial fate, which could translate to
Type I TSC differentiation. When a non-repressor type Hes gene is activated, Hes6, Mash1 is
activated and leads to neuronal differentiation, which would translate to Type II and III
differentiation. The decrease in Notch1 labeling at day 4 and then the subsequent increase
could be evident of this system shifting from differentiating more neuronal type TSCs (low
Notch1 expression) to more glial-like TSCs (higher Notch1 expression) (Bae, Bessho, Hojo,
& Kageyama, 2000).
These results can further be analyzed to show the cycles of activation of Notch1
signaling, which gives crucial insight into the timing of the taste cell replacement cycle. We
could expect to see decreased levels of Mash1 signaling along with the increase in Notch1
signaling due to the suppressing effect of Hes6. This study can be taken at a larger scale to
highlight important points along the taste cell replacement cycle that could be
pharmacologically targeted. This research is comparable to that by Mukherjee, Carroll,
Spees, and Delay (2013), which indicated a drop in the number of BrdU-positive (S-phase
marker for mitosis), proliferating cells in the CV and FF taste papillae. In response to this, the
protective agent amifostine was injected before CYP administration and a significant increase
in the number of proliferative cells was observed. The current research could be used to
identify a crucial time point to intervene pharmacologically. These data therefore suggest an
important role of notch signaling in taste cell replacement.
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Future Directions
To more thoroughly identify Notch1 signaling in the taste cell replacement cycle, the current
study should be replicated and carried out to at least 30 days post-injection. This would allow
for at least one full cycle of taste cells to regrow following challenge by cyclophosphamide.
The trends in Notch1 activation would also be clearer and more crucial points could be
elucidated for potential treatment intervention. To observe the activity of Mash1 in relation to
Notch1 during TSC replacement, double labeling against Mash1 and Notch1 should be
performed. If the nature of these genes withstands in the taste system as it does in the
developing mouse nervous system, an inverse trend should be observed as the TSCs grow
back. Another important avenue to explore and to further support the Mash1 hypothesis,
would be to label specific TSC markers, such as PLCβ2 and SNAP-25. This would give
insight into which TSCs are developing at which timepoints in relation to Notch1 and Mash1
expression.
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